Abstract:Background: Chronically elevated free fatty acid levels can adversely affect pancreatic beta-cells, leading to insulin resistance and eventually type 2 diabetes mellitus (T2DM). Polydatin (PD) from Polygonum cuspidatum has been shown to regulate blood lipid content and lower cholesterol levels. However, there have been no reports on the potential therapeutic effects and actions of PD on lipotoxicity in beta-cells. Purpose: This study aimed to investigate the protective effects of PD on palmitate (PA)-treated INS-1 insulinoma cells and diabetic mice. Methods: Cells were incubated with PA and varying concentrations of PD for 24 h. Viability assays, morphological observations, flow cytometric analysis, western blotting, and reverse transcription-quantitative polymerase chain reaction were used to assess the effects of PD on PA-induced lipotoxicity. Western blotting was used to measure the endoplasmic reticulum stress (ERS) and the levels of autophagy-related factors after incubation with inducers and inhibitors of ERS and autophagy. Diabetic mice were treated with intragastric PD for 6 weeks followed by the measurement of their physiological and blood lipid indices and assessment of the results of histological and immunofluorescence analyses. Results: Treatment with PD after PA exposure enhanced insulin secretion and the expression of diabetes-associated genes. PD promoted beta-cell function by reducing the levels of proteins associated with ERS and autophagy while also attenuating ERS triggered by tunicamycin. PD also reduced tunicamycin-induced autophagy, indicating that it regulated ERS-mediated autophagy and reduced PA-induced cellular dysfunction. In addition, treatment of db/db mice with PD substantially reduced body weight gain, alleviated dyslipidemia, improved beta-cell function, and reduced insulin resistance. Conclusion: These results suggest that PD protects beta-cells from lipotoxicity-induced dysfunction and apoptosis by inhibiting ERS and preventing excessive autophagy. Our study provides a new basis for exploring the potential of PD against beta-cell lipotoxicity and T2DM.

Cyanidin-3-O-Glucoside Ameliorates Palmitic-Acid-Induced Pancreatic Beta Cell Dysfunction by Modulating CHOP-Mediated Endoplasmic Reticulum Stress Pathways

Cyanidin-3-O-Glucoside Supplementation Ameliorates Metabolic Insulin Resistance via Restoration of Nitric Oxide-Mediated Endothelial Insulin Transport

Food-derived cyanidin-3- O -glucoside alleviates oxidative stress: evidence from the islet cell line and diabetic db/db mice

Cyanidin-3-glucoside-rich Extract from Chinese Bayberry Fruit Protects Pancreatic Β Cells and Ameliorates Hyperglycemia in Streptozotocin-Induced Diabetic Mice.

Epigallocatechin gallate attenuated high glucose-induced pancreatic beta cell dysfunction by modulating DRP1-mediated mitochondrial apoptosis pathways

Cyanidin-3-O-Glucoside improves the viability of human islet cells treated with amylin or A<sub>1-42</sub> <i>in vitro</i>

Protective effect of cyanidin-3-O-glucoside on neonatal porcine islets.

Polydatin prevents lipotoxicity-induced dysfunction in pancreatic -cells by inhibiting endoplasmic reticulum stress and excessive autophagy

The Anthocyanin Cyanidin-3-o-β-glucoside, a Flavonoid, Increases Hepatic Glutathione Synthesis and Protects Hepatocytes Against Reactive Oxygen Species During Hyperglycemia: Involvement of a Camp–pka-Dependent Signaling Pathway

Polydatin prevents lipotoxicity-induced dysfunction in pancreatic β-cells by inhibiting endoplasmic reticulum stress and excessive autophagy

Supplementation of Cyanidin-3-O-β-Glucoside Promotes Endothelial Repair and Prevents Enhanced Atherogenesis in Diabetic Apolipoprotein E–Deficient Mice

Exploring the Effects of Cyanidin-3-O-Glucoside on Type 2 Diabetes Mellitus: Insights into Gut Microbiome Modulation and Potential Antidiabetic Benefits.

Potential role of cyanidin 3-glucoside (C3G) in diabetic cardiomyopathy in diabetic rats: An in vivo approach.

A dietary anthocyanin cyanidin-3-O-glucoside binds to PPARs to regulate glucose metabolism and insulin sensitivity in mice

Cyanidin 3-Glucoside Attenuates Obesity-Associated Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed and Db/db Mice Via the Transcription Factor FoxO1.

Cyanidin-3-O-β-glucoside Protects Primary Mouse Hepatocytes Against High Glucose-Induced Apoptosis by Modulating Mitochondrial Dysfunction and the PI3K/Akt Pathway.

Puerarin ameliorates high glucose-induced MIN6 cell injury by activating PINK1/Parkin-mediated mitochondrial autophagy

Antioxidant Effects of Epigallocatechin-3-gallate on the Atc1-6 Pancreatic Alpha Cell Line.

Γ‐glutamylcysteine Alleviates Insulin Resistance and Hepatic Steatosis by Regulating Adenylate Cyclase and IGF‐1R/IRS1/PI3K/Akt Signaling Pathways

Epigallocatechin-3-gallate alleviates type 2 diabetes mellitus via beta-cell function improvement and insulin resistance reduction

Cyanidin-3-O-glucoside Improves Non-Alcoholic Fatty Liver Disease by Promoting PINK1-mediated Mitophagy in Mice.